TRADE NAME OF THE PHARMACEUTICAL PRODUCT
QUALITATIVE AND QUANTITATIVE COMPOSITION OF ACTIVE SUBSTANCES
One suppository contains active substances:
Rectal suppositories 2g each
Distreptaza in suppositories is used in the following cases:
Posology and method of administration
After removing a suppository from the blister pack insert it well up into the rectum. The dosage is dependent on the type and level of exacerbation of the inflammatory state. Use according to the recommendations of a physician.
Dosage regimen in serious states:
Dosage regimen in less serious states:
The average quantity of suppositories applied in the treatment is 8 to 18. The average treatment lasts for 7 - 10 days.
The product should not be in contact with a recently crusted wound or with recently performed suturing, as it may cause the disengagement of the stitches followed by wound bleeding.
Special warnings and precautions for use
Interactions with other medicinal products and other forms of interactions
Pregnancy and lactation
Distreptaza in suppositories should not be used in pregnant and breast feeding women.
Effects on ability to drive and use machines
The medicine does not cause psychophysical deficiency. No effects on the ability to drive or use machines have been observed.
Adverse reactions such as allergic reactions, rise in body temperature and an inclination to bleeding may be observed.
The consequences of an overdose are not known.
Pharmacotherapeutic group: ATC code B 01 AD
Pharmacodynamic and pharmacokinetic properties
The product Distreptaza in suppositories contains two active substances: streptokinase and streptodornase.
Streptokinase is an activating agent of the human blood proenzyme called plasminogen, which under streptokinase influence transforms into plasmin, acting as a fibrinolytic agent in the human blood.
Streptodornase is an enzyme demonstrating the ability to dissolve viscous nucleoprotein mass, dead cells and pus, not affecting live cells and their physiological functions.
Distreptaza in suppositories is used as an independent medicinal product or auxiliary, whose activity facilitates much better access of antibiotics or chemotherapeutics to the focus of inflammation. The product decreases patients’ complaints and considerably shortens the period of treatment.
Composition of the medicinal product and list of excipients.
One suppository contains:
In immediate packaging - 2 years.
Special precautions for storage
Nature and contents of container
Cardboard box contains 1 blister pack with 6 suppositories.
Instruction for use
After removing from the blister pack insert suppository well up into the rectum.